A T→C single-nucleotide polymorphism in the 5' promoter region of the CYP17 gene and a TTTA repeat polymorphism in the exon 4–intron 5 boundary region of the CYP19 gene have been investigated in breast cancer by several studies, with inconsistent results [1,2]. This evidence concerns the gene CYP19A1 and breast carcinoma.